Vimarsana
Biggest News Aggregation in the World

Page 28 - Varuna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Varuna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Varuna Today - Breaking & Trending Today

Ropeway: Govt ready to implement ropeway to Chamundi Hill in Mysuru | - Vimarsana News

Ropeway: Govt ready to implement ropeway to Chamundi Hill in Mysuru |

CM Siddaramaiah announced that the government is ready to implement the ropeway project to Chamundi Hill in Mysuru and urged green activists not to oppose it. Learn more about the importance of the hotel industry in promoting tourism and the demands of the Hotel Owners' Association.

Plan Your Year-End Vacation with Taman Safari Bali - Thailand Business News - Vimarsana News

Plan Your Year-End Vacation with Taman Safari Bali - Thailand Business News

DENPASAR, Indonesia, Dec. 22, 2023 /PRNewswire/ -- As the end of the year approaches, the holiday season is one that many people look forward to. For those

Bristol Myers to buy Karuna Therapeutics for $14 billion - Vimarsana News

Bristol Myers to buy Karuna Therapeutics for $14 billion

New York-based Bristol has been under pressure to expand its drug pipeline amid declining demand for two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, which face generic competition. "We expect KarXT to enhance our growth through the late 2020s and into the next decade," CEO Christopher Boerner said in a statement. Under the terms of the deal, Bristol would pay $330 a share in cash for Karuna, which represents a 53.4% premium to its last closing price.

Source: yahoo.com
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion - Vimarsana News

Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion

New York-based Bristol has been under pressure to expand its drug pipeline amid declining demand for two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, which face generic competition. "We expect KarXT to enhance our growth through the late 2020s and into the next decade," CEO Christopher Boerner said in a statement. Under the terms of the deal, Bristol would pay $330 a share in cash for Karuna, which represents a 53.4% premium to its last closing price.

Source: yahoo.com
Unmanned Aerial Vehicle Market to Worth USD 91.23 Billion - Vimarsana News

Unmanned Aerial Vehicle Market to Worth USD 91.23 Billion

The Global Unmanned Aerial Vehicle (UAV) Market Covered Major Segments By Class (Small UAVs, Tactical UAVs, and Strategic UAVs), By Technology (Remotely...